Fluorescent dye pinpoints tiniest signs of oesophageal cancer

January 16, 2012

(Medical Xpress) -- A fluorescent dye that can be sprayed onto the oesophagus – the food pipe – could be used to detect oesophageal cancer earlier and spare patients unnecessary treatment, according to research published today (Sunday) in Nature Medicine.

When sprayed onto the oesophagus the dye attaches to normal, healthy, cells but is unable to stick to cells or those in the early stages of turning cancerous. This gives doctors a clear signpost to where the disease is developing.  

The researchers, funded by the Medical Research Council (MRC) and Cancer Research UK, studied samples of a particular type of oesophageal cancer called adenocarcinoma, cases of which are soaring. Before this disease develops there is a detectable pre-cancerous stage called Barrett’s oesophagus, which can be easily treated successfully.   

The works by attaching to glycans – molecules on the surface of cells in the oesophagus. When the cells begin to turn cancerous the glycan structures change, meaning that the dye no longer sticks to the surface of these cells. This gives an early warning of where the cancer is developing.

At this point the cancer can be treated with radiofrequency ablation – an electrical current applied to the affected area to kill the cancer cells.

Dr Rebecca Fitzgerald, lead author based at the MRC Cancer Cell Unit in Cambridge, said: “Current methods to screen for oesophageal cancer are controversial – they are costly, uncomfortable for the patient and are not completely accurate. Our technique highlights the exact position of a developing oesophageal cancer, and how advanced it is, giving a more accurate picture. This could spare patients radical surgery to remove the oesophagus that can result in having to eat much smaller more regular meals and worse acid-reflux.”

After pilot studies on large numbers of biopsies the researchers used four patients having removal of early cancer to show how the spray could be used. In two of the cases, pre-cancerous areas were not detected using conventional imaging, but the spray clearly highlighted an area that needed treating.  

In another patient, their entire oesophagus had been removed because a small pre-cancerous area had been identified. Using current techniques it had been impossible to determine how developed the cancer was, but using the fluorescent spray, the researchers found the affected area was small and could have been treated with a less radical procedure.   

Professor Kevin Brindle, one of the researchers based at Cancer Research UK’s Cambridge Research Institute, said: “The benefit of using this dye is that it is specific, relatively cheap and is found in our normal diets so unlikely to cause any unwanted effects at the levels we use. We now need to test our technique in newly diagnosed patients, but it has great potential to be used with current imaging techniques to help improve treatment for oesophageal cancer.”

Oesophageal cancer is the ninth most common cancer in the UK. Each year around 8,000 people are diagnosed with oesophageal cancer and the incidence of the disease in men has risen by more than 50 per cent in a generation.

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: “ is one of the most difficult cancers to detect and treat, with only eight per cent of people with the disease surviving at least five years. We urgently need new ways to detect the cancer earlier, and this dye offers a great opportunity to treat the cancer more promptly and more successfully, potentially saving many lives a year.”

Explore further: 'Sponge on a string' trial launched to try and prevent deadly oesophageal cancer

More information: Bird-Lieberman, E.L., et al Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett’s esophagus. Nature Medicine (2012) DOI: 10.1038/nm.2616

Related Stories

'Sponge on a string' trial launched to try and prevent deadly oesophageal cancer

October 14, 2011
(Medical Xpress) -- Cancer Research UK has launched a large multi-centre trial to test a new device for detecting Barrett’s oesophagus – a condition that puts sufferers at increased risk of developing cancer of ...

Researchers use sugar to halt esophageal cancer in its tracks

January 15, 2012
Scientists working at the Medical Research Council have identified changes in the patterns of sugar molecules that line pre-cancerous cells in the esophagus, a condition called Barrett's dysplasia, making it much easier to ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.